
Invitae Corporation NVTA
Quartalsbericht 2023-Q3
hinzugefügt 08.11.2023
Invitae Corporation P/CF 2011-2026 | NVTA
P/CF Jährlich Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.04 | -4.24 | -22.3 | -10.8 | -9.52 | -3.11 | -3.13 | -2.27 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -1.04 | -22.3 | -7.05 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
28.3 | $ 113.95 | -0.77 % | $ 34.6 B | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 17.3 | -2.92 % | $ 922 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 16.4 | 0.61 % | $ 176 M | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
National Research Corporation
NRC
|
11.9 | $ 17.24 | -0.52 % | $ 386 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 168.88 | 0.33 % | $ 8.37 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 24.9 | 0.67 % | $ 692 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Biodesix
BDSX
|
-1.89 | $ 15.24 | -0.78 % | $ 1.98 B | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 26.95 | -0.97 % | $ 20 B | ||
|
Danaher Corporation
DHR
|
23.3 | $ 191.24 | -0.44 % | $ 136 B | ||
|
DexCom
DXCM
|
17.7 | $ 64.09 | 1.39 % | $ 25 B | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 16.44 | 0.12 % | $ 497 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Guardant Health
GH
|
-72.7 | $ 90.19 | 0.59 % | $ 11.3 B | ||
|
Anixa Biosciences
ANIX
|
-0.0144 | $ 2.61 | 0.77 % | $ 84.7 K | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.13 | -2.07 % | $ 4.89 M | ||
|
BioNano Genomics
BNGO
|
-0.486 | $ 1.13 | -1.7 % | $ 6.15 M | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 108.32 | -1.18 % | $ 8.93 B | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 1.97 | - | $ 8.72 M | ||
|
Illumina
ILMN
|
19.6 | $ 127.78 | 0.03 % | $ 20.3 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Celcuity
CELC
|
-35 | $ 113.83 | -0.35 % | $ 5.32 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 275.15 | 0.21 % | $ 22.9 B | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 76.09 | 0.26 % | $ 5.14 B | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 497.15 | 0.23 % | $ 14.3 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 199.79 | 0.37 % | $ 22.2 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 4.7 | 0.64 % | $ 435 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.706 | $ 4.74 | - | $ 3.73 M | ||
|
NeoGenomics
NEO
|
284 | $ 8.04 | 0.25 % | $ 1.03 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.63 | 0.73 % | $ 2.09 B | ||
|
Natera
NTRA
|
-12.3 | $ 206.6 | 0.84 % | $ 20.3 B | ||
|
Pacific Biosciences of California
PACB
|
-4.48 | $ 1.38 | -2.82 % | $ 414 M | ||
|
Precipio
PRPO
|
56 | $ 25.98 | - | $ 41.7 M | ||
|
Personalis
PSNL
|
-5.62 | $ 6.38 | -3.04 % | $ 378 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B |